A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Clinical trial NCT01190839 · TERMINATED

Trial details

NCT number: NCT01190839
Sponsor: Janssen Biotech, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2010-11-01
Primary completion: 2014-12-01
Enrollment: 297

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.